Answers are grounded in this paper and cite their sources.
In vivo 19fluorine nuclear magnetic resonance spectroscopy was used to measure the brain concentration of fluoxetine and norfluoxetine in five patients with obsessive-compulsive disorder and three with major depression. The mean brain:plasma ratio of the parent drug plus the metabolite was significantly elevated to 2.6 (SD = 1.0) (95% confidence interval = 1.9-3.3). This accumulation may have implications for understanding both the therapeutic and the toxic effects of fluoxetine.
No takes yet. Share an insight, caveat, or question.
Renshaw et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: